Dynavax Technologies
DVAX
$11.20
Share price
1.08%
Change (1 day)
-5.56%
Change (1 year)
Categories
Operating Margin for Dynavax Technologies (DVAX)
Operating Margin as of May 2023 (TTM): 17.64%
According to Dynavax Technologies 's latest financial reports and stock price the company's current Operating Margin is 17.64%. At the end of 2021 the company had an Operating Margin of 17.64%.
Operating Margin history for Dynavax Technologies from 2013 to 2012
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2021 | 17.64% | -110.91% |
| 2020 | -161.63% | -62.7% |
| 2019 | -433.29% | -77.65% |
| 2018 | -1,938.27% | -93.34% |
| 2017 | -29,099.08% | 2757.79% |
| 2016 | -1,018.24% | -61.38% |
| 2015 | -2,636.89% | 220.65% |
| 2014 | -822.35% | 38.67% |
| 2013 | -593.01% | -17.65% |
| 2012 | -720.08% | 227.13% |
| 2011 | -220.12% | 10.78% |
| 2010 | -198.70% | 430.02% |
| 2009 | -37.49% | -42.35% |
| 2008 | -65.02% | -87.11% |
| 2007 | -504.45% | -59.79% |
| 2006 | -1,254.45% | 717.43% |
| 2005 | -153.46% | 34.82% |
| 2004 | -113.83% | -94.71% |
| 2003 | -2,150.61% | 64.47% |
| 2002 | -1,307.57% | 57.93% |
| 2001 | -827.94% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 29.90% | 69.50% | 🇺🇸 USA |
 Amgen AMGN | 34.79% | 97.22% | 🇺🇸 USA |
 Biogen BIIB | 36.44% | 106.58% | 🇺🇸 USA |
 Gilead Sciences GILD | 26.86% | 52.27% | 🇺🇸 USA |
 Merck MRK | 28.49% | 61.51% | 🇺🇸 USA |
 AstraZeneca AZN | -0.70% | -103.97% | 🇬🇧 UK |
 GlaxoSmithKline GSK | 18.87% | 6.97% | 🇬🇧 UK |
 Agenus
AGEN | -9.71% | -155.05% | 🇺🇸 USA |
 Teva Pharmaceutical Industries TEVA | 4.14% | -76.53% | 🇮🇱 Israel |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.